ReCor Medical's RADIANCE-II Pivotal Trial of Paradise uRDN System Completes Enrollment

March 29, 2022—ReCor Medical, Inc., a fully owned subsidiary of Otsuka Medical Devices Co., Ltd., announced completion of enrollment in the RADI

Related Keywords

Germany ,New York ,United States ,Paris ,France General ,France ,Ajay Kirtane ,Michel Azizi ,Georges Pompidou ,Vagelos College Of Physicians ,Hypertension Excellence Center ,Otsuka Medical Devices Co Ltd ,Recor Medical Inc ,Recor Medical ,Coprincipal Investigators ,Paris Cit ,Excellence Center ,Columbia University ,Vagelos College ,Presbyterian Hospital ,Global Paradise System ,Renal Denervation ,Ultrasound Renal Denervation ,Decor ,Otsuka Medical ,Adiance Ii ,Pivotal Trial ,Enrollment Completed ,Hypertension ,Adiance Htn Solo ,Adiance Htn Trio ,